![]() |
Emricasan
- 英文名称:Emricasan
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11170
- cas:254750-02-2
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11170 |
用途 | 科研检测 |
英文名称 | Emricasan |
包装规格 | 1MG |
CAS编号 | 254750-02-2 |
别名 | Emricasan |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:98% by HPLC, NMR (Confirms)
分子式:C26H27F4N3O7
分子量:569.51
溶剂:DMSO (20 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):pan-Caspase inhibitor
Function / Pharmacology:Emricasan is a liver-targeted antiapoptotic pan-caspase inhibitor.1,2 It has been investigated as a hepatoprotective agent in the treatment of liver ischemia3 and NASH/NAFLD liver injury4,5. Emricasan protected SNB-19 cells against cell death induced by Zika virus strains MR766, FSS13025, and PRVABC59.6 Emricasan improves the viability of hPSCs and their differentiated progeny when used in a small molecule cocktail (CEPT) containing chroman 1, polyamines and trans-ISRIB.7
分子式:C26H27F4N3O7
分子量:569.51
溶剂:DMSO (20 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):pan-Caspase inhibitor
Function / Pharmacology:Emricasan is a liver-targeted antiapoptotic pan-caspase inhibitor.1,2 It has been investigated as a hepatoprotective agent in the treatment of liver ischemia3 and NASH/NAFLD liver injury4,5. Emricasan protected SNB-19 cells against cell death induced by Zika virus strains MR766, FSS13025, and PRVABC59.6 Emricasan improves the viability of hPSCs and their differentiated progeny when used in a small molecule cocktail (CEPT) containing chroman 1, polyamines and trans-ISRIB.7